NCT04004962 (SYNOFRESH) is a clinical trial of Infrared spectroscopy in Joint Effusion, sponsored by Rennes University Hospital.

Who is sponsoring NCT04004962?

NCT04004962 is sponsored by Rennes University Hospital.

What drugs are being tested in NCT04004962?

Interventions in NCT04004962: Infrared spectroscopy.

What condition does NCT04004962 study?

NCT04004962 studies Joint Effusion.

Is NCT04004962 still recruiting?

NCT04004962 is currently completed. Last updated 11 August 2021.

Last reviewed 2021-08-11 · How we verify

NCT04004962: SYNOFRESH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Use of Infrared Spectroscopy in Fast Septic Arthritis Diagnosis

Completed Last updated 11 August 2021

What this trial tests

trial testing Infrared spectroscopy in Joint Effusion in 360 participants. Completed in 8 May 2021.

Timeline

16 September 2019

Primary endpoint
8 May 2021

8 May 2021

Quick facts

Lead sponsor	Rennes University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	360
Start date	16 September 2019
Primary completion	8 May 2021
Estimated completion	8 May 2021
Sites	6 locations across France

Drugs / interventions tested

Infrared spectroscopy

Conditions studied

Joint Effusion — all drugs for Joint Effusion →

Sponsor

Rennes University Hospital

Who can join

18 and older, any sex, with Joint Effusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To study the diagnostic performance of infrared spectroscopy on fresh synovial fluids in early septic arthritis diagnosis in patients with acute joint effusion

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Rennes University Hospital trials

Trials by the same sponsor.

NCT07527949 — PASTRAMI : Patient-specific Statistics for Microstructure-augmented Connectomics · NA · not yet recruiting
NCT07449832 — Sperm Epigenome in Hodgkin Lymphoma · NA · not yet recruiting
NCT06950398 — Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers · Phase 2 · not yet recruiting
NCT07188753 — Randomized Controlled Trial Testing the Efficacy of Transcranial Magnetic Stimulation by Accelerated & High-dose Theta-b · NA · not yet recruiting
NCT06898099 — Evaluation of the Efficacy of E2R Hypnotherapy in the Management of Chronic Insomnia in Primary Care (HypERR) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04004962 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rennes University Hospital
Last refreshed: 11 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04004962.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing